Literature DB >> 16227282

Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.

Abel Viejo-Borbolla1, Matthias Ottinger, Eva Brüning, Antje Bürger, Regina König, Emrah Kati, Julie A Sheldon, Thomas F Schulz.   

Abstract

Latency-associated nuclear antigen 1 (LANA-1) of Kaposi's sarcoma-associated herpesvirus (KSHV) mediates the episomal replication of the KSHV genome, as well as transcriptional regulation, in latently infected cells. Interaction of LANA-1 with cellular chromatin is required for both these functions. An N-terminal heterochromatin-binding site in LANA-1 is essential for the replication and maintenance of latent episomes, as well as transcriptional regulation. We have recently described a C-terminal domain in LANA-1 that modulates the interaction with cellular interphase chromatin or elements of the nuclear matrix. Here, we used a series of LANA-1 deletion mutants to investigate the relationship between the different functions of LANA-1 and its interaction with the host chromatin-binding protein Brd2/RING3. Our findings suggest that the C-terminal chromatin-binding domain in LANA-1 is required for multiple LANA-1 functions, including the ability to bind to and replicate viral episomal DNA, to modulate transcription, and to interact with Brd2/RING3. Similar to the recently described tethering of bovine papillomavirus E2 protein to host chromatin via Brd4/MCAP, Brd2/RING3, another member of the Brd family of chromatin-binding proteins, therefore interacts with a chromatin-binding region of another viral latent nuclear protein and could play a role in its multiple functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227282      PMCID: PMC1262589          DOI: 10.1128/JVI.79.21.13618-13629.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

Authors:  W Zhong; H Wang; B Herndier; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.

Authors:  Angela R Brannon; Julia A Maresca; Jef D Boeke; Munira A Basrai; Alison A McBride
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.

Authors:  Michael K Baxter; Maria G McPhillips; Keiko Ozato; Alison A McBride
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.

Authors:  G R Simpson; T F Schulz; D Whitby; P M Cook; C Boshoff; L Rainbow; M R Howard; S J Gao; R A Bohenzky; P Simmonds; C Lee; A de Ruiter; A Hatzakis; R S Tedder; I V Weller; R A Weiss; P S Moore
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

7.  Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1.

Authors:  A Bochkarev; J A Barwell; R A Pfuetzner; W Furey; A M Edwards; L Frappier
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

8.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest.

Authors:  Feng-Qi An; Nicole Compitello; Edward Horwitz; Michael Sramkoski; Erik S Knudsen; Rolf Renne
Journal:  J Biol Chem       Date:  2004-11-02       Impact factor: 5.157

10.  Transient replication of human papillomavirus DNAs.

Authors:  A M Del Vecchio; H Romanczuk; P M Howley; C C Baker
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more
  71 in total

Review 1.  The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.

Authors:  Mary E Ballestas; Kenneth M Kaye
Journal:  Future Microbiol       Date:  2011-12       Impact factor: 3.165

Review 2.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

3.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

4.  Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins.

Authors:  Huaxin Si; Subhash C Verma; Erle S Robertson
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 5.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

6.  Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Meir Shamay; Anita Krithivas; Jun Zhang; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

7.  Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.

Authors:  Brenna Kelley-Clarke; Mary E Ballestas; Viswanathan Srinivasan; Andrew J Barbera; Takashi Komatsu; Te-Ana Harris; Mia Kazanjian; Kenneth M Kaye
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 8.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

9.  Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.

Authors:  Saumya Shree Gupta; Tobias Maetzig; Goedele N Maertens; Azar Sharif; Michael Rothe; Magdalena Weidner-Glunde; Melanie Galla; Axel Schambach; Peter Cherepanov; Thomas F Schulz
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

10.  Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4.

Authors:  Yi-Jan Lin; Takashi Umehara; Makoto Inoue; Kohei Saito; Takanori Kigawa; Moon-Kyoo Jang; Keiko Ozato; Shigeyuki Yokoyama; Balasundaram Padmanabhan; Peter Güntert
Journal:  Protein Sci       Date:  2008-09-24       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.